Story perspectives

Study Reveals Optimal TMS Sites for Schizophrenia Treatment

9/23/2025

47 9

Summary

Story summary

A systematic review synthesizes randomized, sham-controlled trials to identify optimal non-invasive transcranial magnetic stimulation (TMS) sites for schizophrenia.
Endpoints span negative, cognitive, and positive symptoms; trials with concurrent therapies or missing data excluded.
Effect sizes use standardized mean differences with small-sample adjustments; random-effects models address heterogeneity.
PRISMA-compliant; 107 studies included from 4311 articles; bias assessed with Cochrane Risk of Bias Tool 2.0.

1 of 1

Story summary

A systematic review synthesizes randomized, sham-controlled trials to identify optimal non-invasive transcranial magnetic stimulation (TMS) sites for schizophrenia.
Endpoints span negative, cognitive, and positive symptoms; trials with concurrent therapies or missing data excluded.
Effect sizes use standardized mean differences with small-sample adjustments; random-effects models address heterogeneity.
PRISMA-compliant; 107 studies included from 4311 articles; bias assessed with Cochrane Risk of Bias Tool 2.0.